INNERVATE RADIOPHARMACEUTICALS Trademark

Trademark Overview


On Monday, August 30, 2021, a trademark application was filed for INNERVATE RADIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the INNERVATE RADIOPHARMACEUTICALS trademark a serial number of 97001206. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 6, 2024. This trademark is owned by Illumina Radiopharmaceuticals LLC. The INNERVATE RADIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments, and cardiovascular treatments; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents and diagnostic media for bacteriological culture, for medical purposes; companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds, all for medical purposes
innervate radiopharmaceuticals

General Information


Serial Number97001206
Word MarkINNERVATE RADIOPHARMACEUTICALS
Filing DateMonday, August 30, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesAnticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments, and cardiovascular treatments; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents and diagnostic media for bacteriological culture, for medical purposes; companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds, all for medical purposes
NOT AVAILABLE"RADIOPHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINNERVATE RADIOPHARMACEUTICALS LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressENGLEWOOD, NJ 07631

Party NameINNERVATE RADIOPHARMACEUTICALS LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressENGLEWOOD, NJ 07631

Party NameIllumina Radiopharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEnglewood, NJ 07631

Trademark Events


Event DateEvent Description
Friday, June 3, 2022ASSIGNED TO EXAMINER
Thursday, September 2, 2021NEW APPLICATION ENTERED
Wednesday, October 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 13, 2022NON-FINAL ACTION WRITTEN
Monday, June 13, 2022NON-FINAL ACTION E-MAILED
Monday, June 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 1 FILED
Monday, September 18, 2023SOU EXTENSION 1 GRANTED
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2024SOU EXTENSION 2 GRANTED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU EXTENSION 2 FILED
Tuesday, August 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2024SOU EXTENSION 3 FILED
Tuesday, August 6, 2024SOU EXTENSION 3 GRANTED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED